secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001493152-25-006478
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INBS Q2 FY2025 revenue falls 20% YoY; net loss widens to $2.26M; gross margin up 11pts
--------------------------------------------------------------------------------

- Revenue $607,494, down 20% YoY; net loss $2.25M vs $1.97M.
- Gross margin for six months improved to 38.5% from 27.7% on higher cartridge sales.
- FDA 510(k) submitted in Dec 2024; planning US market entry in 2025.
- Cash $2.24M; equity $4.20M as of Dec 31, 2024.
- Added 19 accounts; total 400+ active accounts in 19 countries.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225006478/0001493152-25-006478-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225006478/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-006478

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer